Medelife geht ab
ich denke dass weitere news noch kommen werden...
§
$ 0.01
MDFI
0.00§
Short Interest (Shares Short)
44,000§
Days To Cover (Short Interest Ratio)
0.0§
Short Percent of Float
%§
Short Interest - Prior
50,200§
Short % Increase / Decrease
§-12.35 %
Short Squeeze Ranking™
§
% From 52-Wk High ($ 0.02 )
§-100.00 %
% From 52-Wk Low ($ 0.00 )
§100.00 %
% From 200-Day MA ($ 0.00 )
§100.00 %
% From 50-Day MA ($ 0.01 )
§0.00 %
Price % Change (52-Week)
§512.50 %
Shares Float
§
Total Shares Outstanding
1,133,021,410§
% Owned by Insiders
%§
% Owned by Institutions
%§
Market Cap.
§
$ 10,763,703
Trading Volume - Today
6,969,953§
Trading Volume - Average
36,306,700§
Trading Volume - Today vs. Average
§19.20 %
Earnings Per Share
§
PE Ratio
§
Record Date
2010-FebA
Sector§
Technology
Industry§
§Healthcare Information Services
Exchange
BB§
Data Provided Without Warranty
MedeFile Adds International Biotech Expert to Advisory Board
BOCA RATON, Fla., March 18 /PRNewswire-FirstCall/ -- MedeFile International, Inc. (BULLETIN BOARD: MDFI) , a leader in portable electronic medical records management, announced today the addition of internationally-renowned biotechnology veteran Dr. Gurinder Shahi, M.D., Ph.D., to its Advisory Board.
The co-founder and CMO of Rhapsody Holdings, LLC, Dr. Gurinder Shahi has served as an advisor and consultant to the World Bank and the World Health Organization, as well as governments, corporations and foundations on such progressive health issues as health systems, life science technology innovation/ commercialization management and biotech industry development.
A widely published author, fierce advocate and practicing physician specializing in molecular biology and international health policy, Dr. Shahi said of his appointment, "I am very pleased to be serving on MedeFile's Advisory Board. In the US, MedeFile's innovations in PHR represent the kind of technological advances in healthcare that I have spent my career advocating for internationally."
Working at the central point of healthcare and technology, Dr. Shahi, a trailblazer in the convergence of healthcare and technology, pointed out, "Time and time again I've seen the importance of supporting advances in digital medical records in healthcare." Having spent his career facilitating and promoting innovation, public-private partnership and interdisciplinary collaboration in health care, life sciences and biotechnology, Dr. Shahi added, "It is in this vein that I look forward to helping MedeFile bring its innovations in PHR to the rest of the world."
Dr. Shahi's book, "BioBusiness in Asia: How Asia Can Capitalize on the Life Science Revolution," has been used as a blueprint for biotechnology industry development in several countries around the world. Gurinder has also been actively involved in providing strategic and management input to a range of start-up enterprises and in helping a growing number of US, European and Australian enterprises establish strategic alliances and build their operations in Asia.
With degrees from Harvard and the National University of Singapore, Dr. Shahi served as the Director of Operations and Program Development of the International Vaccine Institute, founding Executive Director and Coordinator of The Asia-Pacific International Molecular Biology Network and founding Director of the Global BioBusiness Initiative.
The author of over 60 published articles in the field, Dr. Shahi is a frequent presenter and speaker at international healthcare conferences worldwide and is presently working on several new initiatives dedicated to the development of technology solutions for health and wellness management.
Milton Hauser, CEO of MedeFile, said, "The addition of Dr. Shahi to our advisory board is a giant step in our ongoing commitment to bringing the innovations of Personal Health Records to the world stage. Gurinder's efforts in helping to bring international health policy into the 21st Century are an inspiration and a beacon to all of us working in healthcare today."
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit http://www.medefile.com/
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
Contact: +1-561-912-3393 ext. 155, Investor@medefile.com
MedeFile International, Inc.
CONTACT: +1-561-912-3393 ext. 155, Investor@medefile.com
Web Site: http://www.medefile.com/
© 2010 PR Newswire
2,5 billionen DOLLAR! da wird auch was für MEDEFILE was dabei sein wir können
gespannt sein auf ein Kursfeuerwerk.
BUYINS.NET Issues MedeFile International SqueezeTrigger Report
* Approximately 357 Million Shares Have Been Shorted In 2010
* 122 Million (34%) of Shares Previously Shorted Began Squeezing at $.0089
NEWPORT BEACH, Calif., March 22, 2010 (GLOBE NEWSWIRE) -- BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on MedeFile International (OTCBB:MDFI) after releasing the latest short sale data through March 16, 2010. The total aggregate number of shares shorted in 2010 is approximately 357 million shares. The SqueezeTrigger price for all shares shorted is $0.0097. Approximately 122 million of shares previously shorted have begun squeezing as the stock closed at $.0089 on March 17, 2010.
Click here to view Report: http://www.buyins.com/reports/mdfi3-17-10.pdf
Click here to view SqueezeTrigger: http://www.buyins.com/images/mdfistr3-17-10.jpg
Click here to view Friction Factor: http://www.buyins.com/images/mdfiff3-17-10.jpg
Friction Factor is used to calculate if a fair market is being made in the shares of (OTCBB:MDFI). 41% of the previous 17 trading days are positive or bullishly-biased and 59% of the trading days are negative or bearishly-biased. BUYINS.NET will monitor MDFI market makers daily for compliance with Fair Market-Making Requirements. Friction determines how many more shares of buying vs. selling it takes to move MDFI higher/lower by 1 cent.
About BUYINS.NET
BUYINS.NET, http://www.buyins.net , monitors trading in all U.S. stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements."
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all U.S. stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all U.S. stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all U.S. stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all U.S. stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. A third party has paid $995 per month to purchase data to be provided in six monthly reports. MDFI has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net , for complete risks and disclosures.
CONTACT: BUYINS.NET
Thomas Ronk
800-715-9999
tom@buyins.net
www.buyins.net
MedeFile Inks Joint Venture Agreement With Transportation Marketing Giant
BOCA RATON, Fla., April 20 /PRNewswire-FirstCall/ -- MedeFile International, Inc. (BULLETIN BOARD: MDFI.OB) , a leader in portable electronic medical records management, announced today the signing of an unprecedented joint venture agreement with The More Network, a premier provider of business-to-business solutions, products and services to the $255.5 billion transportation industry.
The More Network (TMN), consisting of Fleet Management Strategies (http://www.fleetstrategies.com/) and SAFEFIT (http://www.safefitonline.com/) offers products, services and discounts to the more than 500,000 freight carriers, trucking companies and logistics providers in the U.S and Canada, which employ 8.9 million Americans.
The SAFEFIT division of TMN, which focuses on health, training, safety, compliance, document management and secure record maintenance, will market MedeFile's products and services to transportation and logistic companies, fleets and owner/operators throughout North America, including 3.5 million truck drivers in the U.S alone.
As MedeFile's JV Partner in the transportation industry, SAFEFIT will develop and implement strategies for expanding sales of MedeFile's products and services to the millions employed in transportation. With direct access to MedeFile's technology, these individuals and their employers can finally obtain essential health and compliance-related security through the acquisition, organization, and management of their medical records.
"Solutions that reduce safety costs, and give freight carriers some sense of relief are essential to our clients' businesses", said Annamarie Rideout, member of the Board of Directors of SAFEFIT. "Innovative healthcare technology like MedeFile will reduce our clients' operating costs while enhancing their brand in the consumer and driver community."
MedeFile is developing a bundled package with SAFEFIT, incorporating necessary health-related documentation as it pertains to the transportation industry. SAFEFIT will then market this customized service by custom branding MedeFile's signature MedeDrive product with the SAFEFIT logo for sale to its members and clients.
Milton Hauser, CEO of MedeFile, said, "We are extremely excited to have TMN as part our team of allied businesses. The transportation industry is ideally suited for MedeFile's services as accessibility to your medical records is paramount. SAFEFIT is the perfect vehicle for MedeFile to expand its reach into the global transportation and logistics industry."
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit http://www.medefile.com/
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
MedeFile International, Inc.
CONTACT: +1-561-912-3393 ext. 155, Investor@medefile.com
Web Site: http://www.medefile.com/
© 2010 PR Newswire
bringen die auch mal zahlen weiß da jemand etwas?
21-Apr-2010
Annual Report
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS
It should be noted that this Management's Discussion and Analysis of Financial Condition and Results of Operations may contain "forward-looking statements." The terms "believe," "anticipate," "intend," "goal," "expect," and similar expressions may identify forward-looking statements. These forward-looking statements represent the Company's current expectations or beliefs concerning future events. The matters covered by these statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements, including customer acceptance of new products, the impact of competition and price erosion, as well as other risks and uncertainties. The foregoing list should not be construed as exhaustive, and the Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements, or to reflect the occurrence of anticipated or unanticipated events. In light of the significant uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation that the strategy, objectives or other plans of the Company will be achieved. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. We undertake no duty to update this information. More information about potential factors that could affect our business and financial results is included in the section entitled "Risk Factors"
Sales and Marketing
Medefile intends to employ the following marketing strategies in order to generate awareness of Medefile's products and services: direct sales, direct mail, a public relations campaign, including radio and television infomercials, speaking engagements by Medefile's executive officers, participation in trade shows, and alliances and partnerships with third parties.
Medefile's marketing strategy will target the following types of organizations and market segments: Health Maintenance Organizations, Preferred Provider Organizations, managed care organizations, insurance companies, unions, large groups of individuals such as AARP, large and medium sized corporations, home healthcare agencies, retirement communities, nursing homes, public and private schools, summer camps and internet users.
In particular, the MedeFile service is designed to be sold in several distinct ways:
- MedeFile Website - through normal e-commerce mechanisms, patients may enroll in the service directly from the MedeFile website. Membership may be purchased on an annual basis and may be paid all at once, or over time at the patient's discretion.
- Physician Referrals - Patients may enroll based on a doctor's referral. In the event that these physicians are also Medefile CIS customers, they may easily transfer their patients' information into the MedeFile system.
- Large group offerings (e.g., AARP, trade unions) - Large, membership-driven organizations may offer the MedeFile system to their members at a discounted rate, which may be negotiated with Medefile based on the size of the expected enrollment. An additional promotional advantage may be derived from the use of MedeFile through the website of the client organization. Hence, MedeFile functionality may be accessed using each organization's site.
- Insurance companies - Similar to large group offerings identified above, insurance companies will be able to offer the MedeFile service to their insured as a means to decrease the cost of medical care.
Technology
Medefile will use and continue to update the most advanced security measures available. Data transmitted between Web browsers and Web servers over the Internet using TCP/IP is generally susceptible to unauthorized interception. To protect sensitive data, the most common method of protection is data encryption. MedeFile will use the industry standard Secure Sockets Layer (SSL), which is a mechanism to secure Internet traffic so that it cannot be intercepted. SSL utilizes digital certificates to verify the identity and integrity of a web site (such as MedeFile) and to protect the security of transactions by certifying their source and destination.
Competition
There are other companies working in the medical information technology arena such as GE Healthcare, Bio-Imaging Technologies, and Cyber Records. Some competing companies offer a USB key for medical record storage but require the customer to provide or "self-populate" the information to be stored. The information in a self-populated record is limited and is only as accurate as the individual's memory and understanding of their health condition. Other companies expect each customer to obtain their own medical records from their various healthcare providers. Some offer a CD-Rom for record storage. Usually, the CD-Rom cannot be updated with any changes to an individual's medical status or treatment. Therefore, a new CD-Rom needs to be obtained from that company in order for the individual to have the most current, accurate information regarding their health. There are companies that are solely web-based that do not provide the customer the capability to have a copy of their records. In this case, an internet connection is required to view stored documents. In addition, there are companies that do not concentrate on digitizing an individual's medical records but on converting medical facilities' records from paper to electronic format.
The advantage to being a MedeFile member is that MedeFile gathers, consolidates, organizes and securely stores each member's actual medical records on their behalf. The MedeFile membership includes a Digital Health Profile (DHP) which contains the member's general health history, emergency contacts, doctor contacts, family medical history, allergies, medications, and current conditions. A MedeFile membership also includes a MedeDrive, which easily plugs into any PC USB port on most Windows-based computers built in the last four years. (Macintosh version is currently unavailable). The MedeDrive contains the member's emergency medical information, which can be easily accessed by emergency care personnel, and the client's actual medical records which are stored in a secure area of the subscriber's MedeFile. The MedeDrive USB key can be updated easily and as frequently as the member desires at no additional cost.
Employees
From our inception through the period ended December 31, 2009, we have relied primarily on the services of outside consultants. As of December 31, 2009, MedeFile had a total 3 full time employees and 4 consultants.
The employees are covered by employment agreements, and we believe our relations with our employees favorable.
RESULTS OF OPERATIONS
YEAR ENDED DECEMBER 31, 2009 COMPARED TO YEAR ENDED DECEMBER 31, 2008
Revenues
Revenues for the year ended December 31, 2009 totaled $14,264, compared to revenues of $53,235 for the year ended December 31, 2008. The decrease in revenue is primarily related to a decrease in the amount of members and medical record reimbursement revenue received from members. Medical record reimbursement revenue is a dollar for dollar reimbursement for charges from member's doctors for sending updated medical records to MedeFile. The offsetting expense is charged to selling general and administrative expense.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the year ended December 31, 2009 totaled $2,139,381 consisting primarily of consultant compensation, marketing costs and professional fees. This was an increase of $167,152 or approximately 8.5% compared to selling, general and administrative expenses of $1,972,229 for the year ended December 31, 2008. The overall increase in the total selling, general and administrative is primarily due to an increase in headcount, sales, marketing, and business development expenses. We expect expenses to increase in future periods as we continue to solicit new customers. Compensation expenses for the year ended December 31, 2009 totaled $1,723,630 compared to $346,116 for the year ending December 31, 2008. This compensation was for stock-based compensation to consultants.
Depreciation Expense
Depreciation and amortization expense totaled $19,975 and $20,240 for the years ended December 31, 2009 and 2008, respectively.
Interest Expense
Interest expense for the year ended December 31, 2009 was $19,547 a decrease of $18,185 or 48.20% compared to interest expense of $37,732 during the year ended December 31, 2008. The reason for the decrease was due to conversion of related party note payable to common stock.
Net Loss
For the reasons stated above, our net loss for year ended December 31, 2008 was $2,164,639 or $0.00 per share, an increase of $187,481or approximately 9,5%, compared to a net loss of $1,977,158 or $0.01 per share during the year ended December 31, 2008.
Liquidity and Capital Resources
As of December 31, 2009, we had cash of approximately $1,513. Our current liabilities as of December 31, 2009 aggregated $692,957. Working capital deficit at December 31, 2009 was $691,444. We had an accumulated deficit of $13,670,246 and stockholders' deficit of $599,946 at December 31, 2009.
The Company used $319,908 of cash for operating activities during the year ended December 31, 2009. Cash used in investing activities for the year ended December 31, 2009 was $41,145. Cash provided by financing activities for the year ended December 31, 2009 was $354,722, consisting of net proceeds from loans by related and non-related parties.
The Company claims an exemption from the registration requirements of the Act for the private placement of these securities pursuant to Section 4(2) of the Act and/or Regulation D promulgated thereunder since, among other things, these transactions did not involve a public offering, the investors were accredited investors and/or qualified institutional buyers, the investors had access to information about us and their investment, the investors took the securities for investment and not resale, and the Company took appropriate measures to restrict the transfer of the securities.
Additional investments are being sought, but we cannot guarantee that we will be able to obtain such investments. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, the trading price of our common stock and the downturn in the U.S. stock and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations.
Off Balance Sheet Arrangements
We do not have any off balance sheet arrangements as of December 31, 2009 or as of the date of this report.
Critical Accounting Policies
The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect our reported assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities.
We base our estimates and judgments on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. While there are a number of significant accounting policies affecting our consolidated financial statements; we believe the following critical accounting policy involves the most complex, difficult and subjective estimates and judgments:
Revenue Recognition
The Company generates revenue from licensing the right to utilize its proprietary software for the storage and distribution of healthcare information to individuals and affinity groups. For revenue from product sales, the Company recognizes revenue on four basic criteria which must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectibility is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectibility of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required.
Stock-based Compensation
The Company accounts for all compensation related to stock, options or warrants using a fair value based method whereby compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. The Company uses the Black-Scholes pricing model to calculate the fair value of options and warrants issued to both employees and non-employees. Stock issued for compensation is valued using the market price of the stock on the date of the related agreement.
New Accounting Pronouncements
On July 1, 2009, the FASB officially launched the FASB ASC 105 -- Generally Accepted Accounting Principles, which established the FASB Accounting Standards Codification ("the Codification"), as the single official source of authoritative, nongovernmental, U.S. GAAP, in addition to guidance issued by the Securities and Exchange Commission. The Codification is designed to simplify U.S. GAAP into a single, topically ordered structure. All guidance contained in the Codification carries an equal level of authority. The Codification is effective for interim and annual periods ending after September 15, 2009. Accordingly, the Company refers to the Codification in respect of the appropriate accounting standards throughout this document as "FASB ASC". Implementation of the Codification did not have any impact on the Company's consolidated financial statements.
On June 30, 2009, the FASB issued Accounting Standard Update (ASU) No. 2009-01 (Topic 105) - Generally Accepted Accounting Principles - amendments based on - Statement of Financial Accounting Standards No. 168 - The FASB Accounting and Standards Codification and the Hierarchy of Generally Accepted Accounting Principles. Beginning with this Statement the FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, or Emerging Issues Task Force Abstracts. Instead, it will issue Accounting Standard Updates. This ASU includes FASB Statement No. 168 in its entirety. While ASU's will not be considered authoritative in their own right, they will serve to update the Codification, provide the bases for conclusions and changes in the Codification, and provide background information about the guidance. The Codification modifies the GAAP hierarchy to include only two levels of GAAP: authoritative and nonauthoritative. ASU No. 2009-01 is effective for financial statements issued for the interim and annual periods ending after September 15, 2009, and the Company does not expect any significant financial impact upon adoption.
In August 2009, the FASB issued ASU No. 2009-05 - Fair Value Measurements and Disclosures (Topic 820) - Measuring Liabilities at Fair Value. This ASU clarifies the fair market value measurement of liabilities. In circumstances where a quoted price in an active market for the identical liability is not available, a reporting entity is required to measure fair value using one or more of the following techniques: a technique that uses quoted price of the identical or a similar liability or liabilities when traded as an asset or assets, or another valuation technique that is consistent with the principles of Topic 820 such as an income or market approach. ASU No. 2009-05 was effective upon issuance and it did not result in any significant financial impact on the Company upon adoption.
In September 2009, the FASB issued ASU No. 2009-12 - Fair Value Measurements and Disclosures (Topic 820) - Investments in Certain Entities That Calculate Net Asset Value per Share (or its equivalent). This ASU permits use of a practical expedient, with appropriate disclosures, when measuring the fair value of an alternative investment that does not have a readily determinable fair value. ASU No. 2009-12 is effective for interim and annual periods ending after December 15, 2009, with early application permitted. Since the Company does not currently have any such investments, it does not anticipate any impact on its financial statements upon adoption.
In June 2009, the FASB issued SFAS No. 166, "Accounting for Transfers of Financial Assets - an amendment of FASB Statement No. 140". SFAS No. 166 amends SFAS No. 140, "Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities" by eliminating the concept of special-purpose entity, requiring the reporting entity to provide more information about sales of securitized financial assets and similar transactions, particularly if the seller retains some risk to the assets, changes the requirements for the de-recognition of financial assets, and provides for the sellers of the assets to make additional disclosures. This Statement shall be effective as of the Company's first interim reporting period that begins after November 15, 2009. Earlier application is prohibited. The Company does not anticipate any significant financial impact from adoption of SFAS No. 166. As of September 30, 2009, SFAS No. 166 has not been added to the Codification.
In May 2009, the FASB issued FASB ASC 855, "Subsequent Events". This Statement addresses accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or available to be issued. FASB ASC 855 requires disclosure of the date through which an entity has evaluated subsequent events and the basis for that date, the date issued or date available to be issued. The Company adopted this Statement in the second quarter of 2009. As a result the date through which the Company has evaluated subsequent events and the basis for that date have been disclosed in Note 1, Subsequent Events.
In April 2009, the FASB issued an update to FASB ASC 820, "Fair Value Measurements and Disclosures", related to providing guidance on when the volume and level of hactivity for the asset or liability have significantly decreased and identifying transactions that are not orderly. The update clarifies the methodology to be used to determine fair value when there is no active market or where the price inputs being used represent distressed sales. The update also reaffirms the objective of fair value measurement, as stated in FASB ASC 820, which is to reflect how much an asset would be sold in and orderly transaction, and the need to use judgment to determine if a formerly active market has become inactive, as well as to determine fair values when markets have become inactive. The Company adopted this Statement in the second quarter of 2009 without significant financial impact.
In April 2009, the FASB ASC 320, "Investments - Debt and Equity", amends current other-than-temporary guidance for debt securities through increased consistency in the timing of impairment recognition and enhanced disclosures related to credit and noncredit components impaired debt securities that are not expected to be sold. Also, the Statement increases disclosures for both debt and equity securities regarding expected cash flows, securities with unrealized losses, and credit losses. The Company adopted this Statement in the second quarter of 2009 without significant impact to our financial statements.
In April 2009, the FASB issued an update to FASB ASC 825, "Financial Insturments", to require interim disclosures about the fair value of financial instruments". This update enhances consistency in financial reporting by increasing the frequency of fair value disclosures of those assets and liabilities falling within the scope of FASB ASC 825. The Company adopted this update in the second quarter of 2009 without significant impact to the financial statements.
In April 2009, the FASB issued an update to FASB ASC 805, "Business Combinations", that clarifies and amends FASB FASB ASC 805, as it applies to all assets acquired and liabilities assumed in a business combination that arise from contingencies. This update addresses initial recognition and measurement issues, subsequent measurement and accounting, and disclosures regarding these assets and liabilities arising from contingencies in a business combination. The Company adopted this Statement in the second quarter of 2009 without significant impact to the financial statements.
In January 2009, the FASB issued an update to FASB ASC 325, "Investments - Other", which amends the impairments guidance on recognition of interest income and impairment on purchased beneficial interests and beneficial interests that continue to be held by a transferor in securitized financial assets to achieve more consistent determination of whether an other-than-temporary impairment has occurred. The update also retains and emphasizes the objective of an other than-temporary impairment assessment and the related disclosure requirements in FASB ASC 320, "Investments - Debt and Equity Securities", and other related guidance. The adoption of this update in the second quarter of 2009 did not have a significant impact on the Company's financial statements.
In November 2008, EITF issued new guidance under FASB ASC 350, "Intangibles - Goodwill and Other" on accounting for defensive intangible assets". The new guidance applies to all acquired intangible assets in which the acquirer does not intend to actively use the asset but intends to hold (lock up) the asset to prevent its competitors from obtaining or using the asset (a defensive asset). This guidance was adopted by the Company in January 2009 without impact to the financial statements.
In May 2008, the FASB issued an update to FASB ASC 470, "Debt", with respect to accounting for convertible debt instruments that may be settled in cash upon conversion including partial cash settlement. This update applies to convertible debt instruments that, by their stated terms, may be settled in cash (or other assets) upon conversion, including partial cash settlement, unless the embedded conversion option is required to be separately accounted for as a derivative under FASB ASC 815, "Derivatives and Hedging". Additionally, this update specifies that issuers of such instruments should separately account for the liability and equity components in a manner that will reflect the entity's nonconvertible debt borrowing rate when interest cost recognized in subsequent periods. The update is effective for financial statements issued for fiscal years beginning after December 15, 2008, and interim periods within those fiscal years. The Company does not currently have any debt instruments for which this update would apply. This update was adopted in January 2009 without significant financial impact.
In March 2008, the FASB issued an update to FASB ASC 815, "Derivatives and Hedging" This update is intended to enhance the current disclosure framework in FASB ASC 815. Under this update, entities will have to provide disclosures about
(a) how and why and entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under FASB ASC 815 and its related interpretations, and (c), how derivative instruments and related hedged items effect an entity's financial position, financial performance and cash flows. This update is effective for all financial statements issued for fiscal and interim periods beginning after November 15, 2008. The Company does not currently have any derivative instruments, nor does it engage in hedging activities, therefore, the Company's adoption of this update in the first quarter of 2009 was without significant financial impact.
Certain amounts previously reported have been reclassified to conform to the current year presentation.
da können wir noch lange warten
Dieses Posting: versenden | melden Diskussion drucken
was haltet ihr davon???? hört sich nicht so gut an oder!!! glaube da müssen wir noch lange warten bis hir was geht oder?? bitte eure meinungKeks
junge such selber und kopiere meine sachen nicht in wo ,mit denen habe ich fertig
Period Ending Endenden Zeitraum Dec 31, 2009 31. Dezember 2009 Sep 30, 2009 30. September 2009 Jun 30, 2009 30. Juni 2009 Mar 31, 2009 31. März 2009
Total Revenue Total Revenue 2 2 5 5 3 3 5 5
Cost of Revenue Cost of Revenue - - - - - - - -
Gross Profit Bruttogewinn 2 2 5 5 3 3 5 5
§Operating Expenses Betriebliche Aufwendungen
§Research Development Forschung, Entwicklung - - - - - - - -
§Selling General and Administrative Vertriebs-, Verwaltungs- 1,033 1033 353 353 244 244 509 509
§Non Recurring Non Recurring - - - - - - - -
§Others Andere 4 4 4 4 6 6 6 6
§
§Total Operating Expenses Summe betriebliche Aufwendungen - - - - - - - -
Operating Income or Loss Betriebsergebnis Gewinn oder Verlust (1,036) (1036) (352) (352) (247) (247) (510) (510)
§Income from Continuing Operations Ergebnis aus fortzuführenden Geschäftsbereichen
§Total Other Income/Expenses Net Total übrige Erträge / Aufwendungen Net - - - - - - - -
§Earnings Before Interest And Taxes Gewinn vor Zinsen und Steuern (1,036) (1036) (352) (352) (247) (247) (510) (510)
§Interest Expense Zinsaufwand 8 8 4 4 4 4 3 3
§Income Before Tax Ergebnis vor Steuern (1,044) (1044) (357) (357) (251) (251) (513) (513)
§Income Tax Expense Ertragssteueraufwand - - - - - - - -
§Minority Interest Minderheitenanteile - - - - - - - -
§
§Net Income From Continuing Ops Reingewinn aus fortzuführenden Ops (1,044) (1044) (357) (357) (251) (251) (513) (513)
§Non-recurring Events Einmalige Events
§Discontinued Operations Nicht fortgeführte Geschäftsbereiche - - - - - - - -
§Extraordinary Items Außerordentliche Posten - - - - - - - -
§Effect Of Accounting Changes Effekt aus Änderungen der Rechnungslegung - - - - - - - -
§Other Items Andere Artikel - - - - - - - -
Net Income Net Income (1,044) (1044) (357) (357) (251) (251) (513) (513)
Preferred Stock And Other Adjustments Vorzugsaktien und sonstige Berichtigungen - - - - - - - -
Net Income Applicable To Common Shares Net Income Shares für die gemeinsame ($1,044) ($ 1.044) ($357) ($ 357) ($251) ($ 251) ($513) ($ 513)
§
$ 0.01
MDFI
0.00§
Short Interest (Shares Short)
87,100§
Days To Cover (Short Interest Ratio)
0.0§
Short Percent of Float
%§
Short Interest - Prior
25,000§
Short % Increase / Decrease
§248.40 %
Short Squeeze Ranking™
§
% From 52-Wk High ($ 0.02 )
§-233.33 %
% From 52-Wk Low ($ 0.00 )
§100.00 %
% From 200-Day MA ($ 0.00 )
§100.00 %
% From 50-Day MA ($ 0.01 )
§-66.67 %
Price % Change (52-Week)
§455.60 %
Shares Float
0§
Total Shares Outstanding
1,463,021,410§
% Owned by Insiders
§0.00 %
% Owned by Institutions
§0.00 %
Market Cap.
§
$ 9,509,639
Trading Volume - Today
15,394,492§
Trading Volume - Average
8,144,300§
Trading Volume - Today vs. Average
§189.02 %
Earnings Per Share
§
PE Ratio
§
Record Date
2010-MayA
Sector§
Technology
Industry§
§Healthcare Information Services
Exchange
§BB
Small cap stocks Medefile International, Cannon Exploration, and Jedi Mind are reviewed from a technical point of view.
By James E. Brumley
Published: May 13, 2010 7:36:13 AM PDT
Print Email
0 Comment(s) - Post a Comment
Rating N/A
While the multi-month downtrend from Jedi Mind Inc (PINK:JEDM) hasn't exactly been thwarted with today's 24% pop, today's move at least offers hope as it is a step in the right direction. The fact that the buying volume behind the rally from JEDM is the strongest volume day we've seen in months (and the day just got started) adds to the potential optimism. The key here will be getting back above the 50-day average line at $0.0389, which has been a problematic resistance area for Jedi Mind Inc shares since the downtrend started last October.
Though the pullback between early January and early May was a significant one for Medefile International, Inc. (OTC:MDFI), this small cap stock managed to reverse course on the 7th thanks to support at the 200-day moving average line. Since then, MDFI has rallied from a low of $0.0044 to the current price of $0.0069, where it's hit a ceiling at its 50-day moving average line. If that line can be hurdled, Medefile International has a decent shot art making it back up to the turblence zone around $0.012.